Trials / Not Yet Recruiting
Not Yet RecruitingNCT06715189
Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus
Correlation Between Serum Adiponectin and Resistin Levels and Degree of Hepatic Fibrosis In Metabolic Dysfunction _Associated Steatotic Liver Disease (MASLD)With Type2 Diabetes Mellitus
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Metabolic dysfunction asociated steatotic liver disease prevalence is 25%world wide diabetic patients have a risk for MASLD then have hepatic fibrosis so we study correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic fibrosis In Metabolic dysfunction asociated steatotic liver disease in patients with type2 Diabetes Mellitus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | serum Adiponectine and Resistin | corrolation between serum adiponectin and Resistin levels and degree of hepatic fibrosis |
| DIAGNOSTIC_TEST | fibroscan | hepatic fibrosis detection in type 2 diabetes mellutis |
Timeline
- Start date
- 2024-12-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-30
- First posted
- 2024-12-04
- Last updated
- 2024-12-04
Source: ClinicalTrials.gov record NCT06715189. Inclusion in this directory is not an endorsement.